UY28739A1 - Nuevos compuestos de piridin-2-ona útiles como inhibidores de trombina - Google Patents

Nuevos compuestos de piridin-2-ona útiles como inhibidores de trombina

Info

Publication number
UY28739A1
UY28739A1 UY28739A UY28739A UY28739A1 UY 28739 A1 UY28739 A1 UY 28739A1 UY 28739 A UY28739 A UY 28739A UY 28739 A UY28739 A UY 28739A UY 28739 A1 UY28739 A1 UY 28739A1
Authority
UY
Uruguay
Prior art keywords
piridin
new
compounds useful
thrombin inhibitors
conditions
Prior art date
Application number
UY28739A
Other languages
English (en)
Inventor
Tord Inghardt
Kristina Berggren
Ola Fjellstrom
David Gustafsson
Mats Nagard
Ingemar Nilsson
Stephen Hanessian
Eric Therrien
Malken Bayrakdarian
Frederick-Banting
Ojvind Davidsson
Daniel Simard
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400254A external-priority patent/SE0400254D0/xx
Priority claimed from SE0401658A external-priority patent/SE0401658D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28739A1 publication Critical patent/UY28739A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporciona un compuesto de fórmula I en donde la línea punteada, R1, R2, R3a, R3b, A, D, E, G y L tienen los significados proporcionado en la memeoria descriptiva, siendo dichos compuestos útiles como inhibidores competitivos de serinproteasas similares a al tripsina ( o como profármacos de los mismos), tal como la trombina, y por lo tanto, en particular, en el tratamiento de condiciones en dondenla inhibición de la trombina resulta beneficiosa (por ejemplo, condiciones tales como tromboembolismos en donde resulte necesaria la inhibición de la trombina y/o condiciones para las cuales se indica una terapia anticoagulante).
UY28739A 2004-02-06 2005-02-04 Nuevos compuestos de piridin-2-ona útiles como inhibidores de trombina UY28739A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400254A SE0400254D0 (sv) 2004-02-06 2004-02-06 New compounds
SE0401658A SE0401658D0 (sv) 2004-06-24 2004-06-24 New compounds

Publications (1)

Publication Number Publication Date
UY28739A1 true UY28739A1 (es) 2005-09-30

Family

ID=34840320

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28739A UY28739A1 (es) 2004-02-06 2005-02-04 Nuevos compuestos de piridin-2-ona útiles como inhibidores de trombina

Country Status (15)

Country Link
US (1) US20070161643A1 (es)
EP (1) EP1713774A1 (es)
JP (1) JP2007520550A (es)
KR (1) KR20060135797A (es)
AR (1) AR047521A1 (es)
AU (1) AU2005210451A1 (es)
BR (1) BRPI0507316A (es)
CA (1) CA2553604A1 (es)
IL (1) IL176941A0 (es)
NO (1) NO20063955L (es)
RU (1) RU2006130685A (es)
SA (1) SA05260019B1 (es)
TW (1) TW200529840A (es)
UY (1) UY28739A1 (es)
WO (1) WO2005075424A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514742A (ja) * 2003-12-18 2007-06-07 アストラゼネカ アクチボラグ トロンビンの阻害薬として有用な新規５，６−ジヒドロピリジン−２−オン化合物
EP1893601A1 (en) * 2005-06-17 2008-03-05 AstraZeneca AB Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
CN101243070A (zh) * 2005-06-17 2008-08-13 阿斯利康(瑞典)有限公司 抑制凝血酶的2,4-二氧代-3,4-二氢嘧啶衍生物
US11666888B2 (en) 2018-02-05 2023-06-06 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
KR20010042287A (ko) * 1998-03-31 2001-05-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 세린 프로테아제 억제제로서의 퀴놀론
US6946283B2 (en) * 2001-01-05 2005-09-20 William Marsh Rice University Ginkgo biloba levopimaradiene synthase
JP2004520399A (ja) * 2001-02-09 2004-07-08 メルク　エンド　カムパニー　インコーポレーテッド トロンビン阻害剤
US20040106626A1 (en) * 2001-10-03 2004-06-03 Pharmacia Corporation 6-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade

Also Published As

Publication number Publication date
TW200529840A (en) 2005-09-16
CA2553604A1 (en) 2005-08-18
WO2005075424A1 (en) 2005-08-18
EP1713774A1 (en) 2006-10-25
NO20063955L (no) 2006-09-05
RU2006130685A (ru) 2008-03-20
SA05260019B1 (ar) 2008-08-30
JP2007520550A (ja) 2007-07-26
AU2005210451A1 (en) 2005-08-18
KR20060135797A (ko) 2006-12-29
BRPI0507316A (pt) 2007-06-26
AR047521A1 (es) 2006-01-25
US20070161643A1 (en) 2007-07-12
IL176941A0 (en) 2006-12-10

Similar Documents

Publication Publication Date Title
ECSP099476A (es) Compuestos carboxamida y su uso como inhibidores de calpaína
BR112012019042A8 (pt) compostos inibidores de serina protease tipo tripsina, seu uso, e seus processos de preparação
CO6501153A2 (es) Inhibidores macrociclicos de serina proteasa
CL2017003496A1 (es) Formas cristalinas de un inhibidor de tirosina quinasa de bruton.
MX2009004320A (es) Inhibidores de serina proteasa tipo tripsina, y su preparacion y uso.
AR073138A1 (es) Derivados de dioxa-biciclo (3.2.1) octano- 2,3,4-triol
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
BRPI0807904A2 (pt) Inibidores das serina proteases para o tratamento de infecções de hcv
CL2009001214A1 (es) Compuestos derivados de heterociclo, moduladores de serina proteasas composicion fa<rmacaeutica que los comprende; y su uso en el tratamiento de trastornos tromboembolicos
DE602007014186D1 (de) Triazin-11-beta-hydroxysteroid-dehydrogenase-artige hemmer
PT1423391E (pt) Pirrolopirimidinas como agentes para a inibicao de proteases de cisteina
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
BRPI0514372A (pt) inibidores de tiazol de frutose 1, 6-bisfosfatase
ECSP077269A (es) Ácidos de oxazolo - naftilo como moduladores del ácidos de oxazolo - naftilo como moduladores del inhibidor del activador de plasminógeno tipo 1 (pai-1)
ECSP11011503A (es) Compuestos carboxamida y su uso como inhibidores de calpaína.
EA201000070A1 (ru) Модуляторы калликреина 7
ECSP099389A (es) Nuevas formas cristalinas
UY28739A1 (es) Nuevos compuestos de piridin-2-ona útiles como inhibidores de trombina
UY31203A1 (es) Nuevos compuestos de aza-biciclohexano útiles como inhibidores de trombina
ECSP056106A (es) Compuestos novedosos de acido fosfonico como inhibidores de las serina proteasas
WO2008015139A3 (en) Inhibitors of zinc proteases thioaryl substituted and their use
DOP2010000402A (es) Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina
AR039937A1 (es) Derivados de azetidina como inhibidores de tripsina proteasas
NO20030675D0 (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
MY132033A (en) New mandelic acid derivatives and their use as thrombin inhibitors

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160419